Background This study evaluated the relation between body iron stores and coronary artery disease. It has been suggested that total body iron stores are an independent risk factor for acute myocardial infarction (AMI).
Methods and Results Our study population consisted of 46 932 members of a prepaid health plan who were 230 years old and who received a standard health check between 1969 and 1971. Blood collected during this examination was analyzed for serum iron and total iron-binding capacity. Transferrin saturation (TS), calculated as (serum iron/total ironbinding capacity) x 100, was categorized as low (.10%), normal (11% to 61%), or elevated (.62%). Hospital TS was categorized as (1) .10% (low), (2) 11% to 61% (normal, used as referent), and (3) .62% (elevated). Analysis of AMI-related hospital stays was performed overall and by sex, and age-specific (<55, 55 to 64, 65 to 74, or .75 years) incidence rates were obtained for each TS level. Age-adjusted rates were calculated by using the direct method with the observed person-year distribution as the standard population. Proportional hazards regression models were used to assess the significance of TS as a risk factor for AMI while controlling for age, race, and risk factors for AMI as covariates. Statistical significance was considered at a=.05. The risk factor variables based on self-report were education, smoking status, alcohol consumption, family history of heart disease, and history of diabetes as diagnosed by a physician. Examination During follow-up, 969 men and 871 women were treated in the hospital for AMI. Table 2 shows ageadjusted AMI rates by TS level for men and women. The rate for men with TS level .10% was lower than for men with normal or elevated levels; among women, rates were similar for the two lower TS levels and somewhat higher for women with an elevated TS level. Table 3 shows relative risk of AMI-related hospitalization for the low and the elevated TS level groups compared with the normal TS level group when the data were adjusted for other known coronary disease risk factors. The relative risk of 1.3 for the elevated TS (Table 4) . Discussion proposed that reduced iron stores can protect against ischemic heart disease by inhibiting the oxidative modification of low-density lipoprotein (LDL) and possibly by decreasing postischemic myocardial injury. Salonen et all observed that serum ferritin was an independent risk factor for AMI in a cohort of 1931 randomly selected Finnish men who were followed for a mean of 3 years. Their observation that the association between ferritin and AMI was stronger in men with an elevated LDL level was considered to support the hypothesis of Salonen et al. Sullivan2 speculated that if iron stores did affect the modification of LDL cholesterol and myocardial reperfusion injury, maximal protection from coronary disease should be found among iron-deficient subjects. He further speculated that this protective effect might account in part for the very low incidence of coronary disease in premenopausal women. We looked for an association between AMI and stored iron among 46 932 subjects whose serum iron and TIBC were measured and who were followed for a mean of 14.1 years.
Both serum ferritin6 and TS <15%7 have been used to identify persons with anemia due to iron deficiency. However, Cook et a18 assessed a population of 1564 subjects for iron deficiency defined as TS < 15%, ferritin <12 ng/mL, or erythrocyte protoporphyrin >100 ,ug/ mL. They found that no one parameter was sufficient to identify an iron-deficient population and that accuracy of iron deficiency detection in population surveys can be improved substantially by using two or three of these measurements. Neither erythrocyte protoporphyrin nor serum ferritin measurements were obtained for our subjects. We therefore used TS .10% to define our iron-deficient population. Considering the prevalence of anemia and microcytosis among our subjects with TS <10%, we are confident that this group included a substantial proportion of iron-deficient subjects. Our results did not show iron deficiency defined as TS c 10% to be protective against AMI. The low TS group, however, was relatively small.
The anemia of chronic disease can be associated with low TS. Our results were unchanged after we excluded subjects with a TIBC <250 from the group with TS . 10%. As a result, a protective effect of iron deficiency against AMI was unlikely to be obscured by inclusion of subjects with chronic disease in our population of patients with low TS.
Salonen et all found that the association between ferritin and AMI was stronger among men with elevated LDL cholesterol level than among those without elevated LDL cholesterol level. We did not have LDL cholesterol measurements for our study population, but we found no association between iron stores as determined by TS and AMI among study subjects with a total cholesterol level in the highest quartile.
Ferritin level measurements, an excellent method of assessing increased total body iron stores,9 were not performed in our study population. However, we used TS to identify a study population likely to have increased iron stores. In normal persons, iron absorption is inhibited as iron stores accumulate, and iron overload is prevented. In persons with hereditary hemochromatosis, feedback inhibition of iron absorption is impaired, and therefore increased iron stores are common.10 HLA-linked hereditary hemochromatosis is estimated to occur in 1 in 200 persons,'1 and TS .62% is the best, simply measured indicator of homozygosity for the hemochromatosis gene. 12 We therefore used TS >62% to identify a population likely to include many subjects with hemochromatosis and therefore to have increased iron stores. While our results suggested an increased AMI risk for this elevated TS group, the relative risk of 1.3, not statistically significant, was much lower than that reported by Salonen et al. ' Some authors have recommended that TS be measured when the patient is in a fasting state.13 Our subjects were not instructed to fast, but the time since they had last eaten was recorded. We found no relation between serum iron, TIBC, or TS and the time since our subjects had last eaten.
In summary, by using TS as a measure of iron stores, we have been unable to confirm Salonen's observation that iron stores are an independent risk factor for AMI.
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Iron stores are not associated with acute myocardial infarction.
